Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A Medicare pilot program will allow private companies to use artificial intelligence to review older Americans’ requests for ...

Allied Market Research published a report, titled, "Cardiovascular Diagnostic Device Market by Type (Electrocardiogram Devices, Holter Monitoring Devices, and Others), End User (Hospitals, Cardiac ...

Six months on the road with the Dean campaign. By Kate Albright-Hanna CNN Producer . WASHINGTON (CNN) -- It was around 8 a.m., windy and 4 degrees when Dean campaign manager Joe T ...

Artificial intelligence is moving from the lab into the clinic, and one of its most provocative promises is that it might ...

Sleep apnea can be the cause of many diseases. Thanks to the Derila Sleep Apnea Pillow, there's an affordable solution. Get ...

Somewhere in that chain, a life slipped through. This is the human wreckage left behind when Kenya's ambitious digital health ...

Hundreds of Syrians hoping to return to their home country from Europe and Turkey to mark a year since the fall of the Assad ...

Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ...

IBM will reportedly pay $11B for the data streaming company. Lilly, Pfizer, J&J in China’s private insurance catalog. White ...

Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. The battle to ...

Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...